Carbonic Anhydrases and Metabolism

Area of Science:

• Biochemistry and Pharmacology
• Enzymology
• Metabolic Regulation

Background:

• Carbonic anhydrases (CAs) are crucial enzymes involved in essential physiological processes, including metabolism and pH homeostasis across diverse organisms.
• Pharmacological targeting of CAs is a recent but rapidly developing area, with implications for various therapeutic applications.
• The seven known genetic families of CAs play vital roles in biosynthetic pathways and maintaining cellular pH.

Discussion:

• CA inhibitors demonstrate antiobesity effects by directly inhibiting lipogenesis.
• Transmembrane isoforms CA IX and XII are critical regulators of hypoxic tumor metabolism, promoting an acidic extracellular environment and supplying bicarbonate for proliferation.
• The special issue explores the multifaceted roles of CAs in cancer metabolism and their potential for developing innovative antitumor therapies and imaging agents.

Key Insights:

• CA inhibition offers a direct mechanism for reducing lipogenesis, presenting a therapeutic strategy for obesity.
• Targeting CA IX and XII in tumors can disrupt their metabolic adaptation to hypoxia, offering a novel approach to cancer treatment.
• Understanding CA functions in bacteria and algae opens avenues for exploring their metabolic roles in these organisms.

Outlook:

• Further research into CA inhibitors could lead to new treatments for metabolic disorders and cancer.
• Developing specific CA-targeting agents may enable precise modulation of tumor microenvironments for enhanced therapeutic efficacy.
• Investigating CA roles in microbial metabolism could uncover new biotechnological applications.